COMPANY PROFILE

Braeburn

Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction

Washington DC, United StatesFounded 2012Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2018

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Braeburn

Braeburn is a healthcare startup dedicated to addressing the opioid use disorder (OUD) crisis in America. The company focuses on developing next-generation medications designed to help patients overcome opioid addiction. These treatments are intended to be used alongside counseling and support services to provide a comprehensive approach to recovery. Braeburn's mission is to support patients as they work to reintegrate into their communities and rebuild their lives.

The company primarily serves individuals suffering from OUD, a significant public health issue that affects millions of Americans. By targeting this specific patient group, Braeburn operates within the healthcare and pharmaceutical markets, which are both highly regulated and essential for public health.

Braeburn's business model revolves around the research, development, and commercialization of innovative therapies for OUD. The company invests heavily in R&D to create effective treatments that can be brought to market. Revenue is generated through the sale of these medications to healthcare providers, clinics, and directly to patients. Additionally, Braeburn may engage in partnerships with other healthcare organizations to expand the reach of its therapies.

In summary, Braeburn is a mission-driven company focused on combating the opioid epidemic through advanced medical treatments. It serves a critical need in the healthcare market by providing solutions that help patients recover from addiction and reintegrate into society.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: Washington DC, United States
Employees: 285
Open positions: 9
Dealroom signal: 54.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Addiction, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Jan 2018	$110M	$440M	New Leaf Venture Partners · Avista Healthcare Partners · Apple Tree Partners · Rock Springs Capital	—
DEBTDebt	Jan 2018	$110M	—	New Leaf Venture Partners · Avista Healthcare Partners · Apple Tree Partners · Rock Springs Capital	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Braeburn website traffic

Latest recorded traffic for Braeburn is 27K monthly website visits, up 17.4% over the last three months. Braeburn's team grew 16.3% over the past year.

Latest monthly visits27K 3-month web change+17.4% 1-year team growth+16.3%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Key Account Manager, Worcester, MA New Remote - Worcester, MAWorcester, Massachusetts, United States, Northern America, Americas · Sales · Aug 25, 2026 Office Manager New Plymouth Meeting, PAPlymouth, Pennsylvania, United States, Northern America, Americas · Other · Aug 23, 2026 Key Account Manager, Louisville, KY New Remote - Louisville, KYLouisville, Kentucky, United States, Northern America, Americas · Sales · Jul 26, 2026 Key Account Manager, North Florida New Remote - North FloridaSilver Spring, Washington, Montgomery County, District of Columbia, United States · Sales · Jul 26, 2026 Senior Manager, Medical Affairs Operations Plymouth Meeting, PA (Hybrid) or RemotePlymouth, Pennsylvania, United States, Northern America, Americas · Other · Jul 26, 2026 Senior Manager, Medical Affairs OperationsPlymouth Meeting, PA · Other · Jul 22, 2026 Director, Clinical Quality AssurancePlymouth Meeting, PA · Other · Jul 10, 2026 Associate Director, Health Economics & Outcomes Research (HEOR)Silver Spring, Washington, Montgomery County, District of Columbia, United States · Other · Jul 10, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ANAmygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction	Palo Alto, United States	Operational	3	$7.6M	—
ASATAI Life SciencesA biotechnology company pioneering mental health innovation	Berlin, Germany	Acquired
EIEmerzene IncRevolutionize CRISPR gene editing for non-addictive pain relief	Dublin, Ireland	Operational
ENEmpyrean NeuroscienceUsing genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare	New York City, United States	Operational
RMRebel MedicineBiotech developing safe and effective alternatives to opioids	Salt Lake City, United States	Operational
DTDiamond TherapeuticsDeveloping accessible, low-dose therapies for mental health conditions	Toronto, Canada	Operational
DEDemeRxDemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates as medication-assisted therapies for opioid addiction	Fort Lauderdale, United States	Operational
CYCybinCybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms	Ontario, United States	Operational